<Suppliers Price>

Pro-Leu-Gly-NH2

Names

[ CAS No. ]:
2002-44-0

[ Name ]:
Pro-Leu-Gly-NH2

[Synonym ]:
Oxytocin C-terminal tripeptide
Melanocyte stimulating hormone release inhibiting factor
MSH-release inhibiting factor I
MIF-I Melanostatin Oxytocin fragment 7-9
L-Prolyl-L-leucylglycinamide
MFCD00037866
MELANOSTATIN
EINECS 217-902-7
Pro-Leu-Gly-NH2
L-Prolyl-L-leucylglycylamide
melanocyte-stimulating hormone release-inhibiting factor-1
MIF-I
Prolylleucylglycine amide
7-9-Oxytocin
MIF-1

Biological Activity

[Description]:

MIF-1 (Melanostatin), an endogenous brain peptide, is a potent dopamine receptor allosteric modulator. MIF-1 inhibits melanin formation. MIF-1 blocks the effects of opioid receptor activation to modulate the analgesic effects of morphine and stress-induced analgesia (SIA). MIF-1 accesses from the blood to the CNS by directly crossing the blood-brain barrier (BBB)[1][2][3].

[Related Catalog]:

Signaling Pathways >> GPCR/G Protein >> Dopamine Receptor
Signaling Pathways >> Neuronal Signaling >> Dopamine Receptor
Research Areas >> Neurological Disease

[In Vitro]

MIF-1 (Melanostatin, 1 μM) provokes a reversible hyperpolarization and a suppression of spontaneous action potentials[2].

[In Vivo]

MIF-1 (Melanostatin, 1 mg/kg; i.p.; once, for 1 hour; male Wistar rats) modulates the analgesic effects of morphine and stress-induced analgesia (SIA)[1]. MIF-1 (Melanostatin, 1 mg/kg; i.p.; daily, for 8 weeks; Sprague-Dawley rats) attenuates spiroperidol-induced impairment of development of striatal dopamine D2 receptors in rats[3]. Animal Model: Male Wistar rats[1] Dosage: 1 mg/kg Administration: Intraperitoneal injection; once, for 1 hour Result: Decreased the analgesic effect of morphine. Increased the pain threshold for at least 1 h. Animal Model: Sprague-Dawley rats[3] Dosage: 1 mg/kg Administration: Intraperitoneal injection; daily, for 8 weeks Result: Attenuated the ontogenic impairment of striatal D2 receptors that was produced by spiroperidol (HY-B1371) treatment.

[References]

[1]. Bocheva A, et, al. Antiopioid properties of the TYR-MIF-1 family. Methods Find Exp Clin Pharmacol. 2004 Nov;26(9):673-7.

[2]. Valentijn JA, et, al. Melanostatin (NPY) inhibited electrical activity in frog melanotrophs through modulation of K+, Na+ and Ca2+ currents. J Physiol. 1994 Mar 1;475(2):185-95.

[3]. Saleh MI, et, al. MIF-1 attenuates spiroperidol alteration of striatal dopamine D2 receptor ontogeny. Peptides. 1989 Jan-Feb;10(1):35-9.

Chemical & Physical Properties

[ Density]:
1.147g/cm3

[ Boiling Point ]:
626.2ºC at 760mmHg

[ Molecular Formula ]:
C13H24N4O3

[ Molecular Weight ]:
284.35500

[ Flash Point ]:
332.5ºC

[ Exact Mass ]:
284.18500

[ PSA ]:
113.32000

[ LogP ]:
0.68170

[ Vapour Pressure ]:
1.34E-15mmHg at 25°C

[ Index of Refraction ]:
1.51

MSDS

Precursor & DownStream


Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.